Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes

Vatankulu, B.; Aksoy, S.; Asa, S.; SAğER, MUHAMMET; SAYMAN, HALUK; Halac, M.; SÖNMEZOĞLU, KERİM

doi:10.1016/j.remn.2015.07.001

Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes

Vatankulu B., Aksoy S. Y., Asa S., SAğER M. S., SAYMAN H. B., Halac M., ...Daha Fazla

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, cilt.35, sa.1, ss.17-21, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 35 Sayı: 1
Basım Tarihi: 2016
Doi Numarası: 10.1016/j.remn.2015.07.001
Dergi Adı: REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.17-21
Anahtar Kelimeler: Paraneoplastic neurological syndrome, Positron emission tomography, Malignancy, Paraneoplastic antibodies, POSITRON-EMISSION-TOMOGRAPHY, CT, AUTOANTIBODIES, MALIGNANCY, DISORDERS, TUMORS
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Objective: There is still no consensus about whether to perform PET/CT to detect carcinoma in paraneoplastic neurological syndromes (PNS) in patients with or without antibodies. The aim of this study is to determine the diagnostic accuracy of PET/CT and antibodies in patients with PNS.